Verrica Pharmaceuticals Inc — 四半期キャッシュフロー (NASDAQ:VRCA) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 54.13 M42.18 M39.11 M40.9 M47.13 M 負債合計 63.99 M60.75 M56.59 M57.94 M22.39 M 純資産合計 -9.86 M-18.58 M-17.48 M-17.04 M24.74 M 負債および純資産合計 54.13 M42.18 M39.11 M40.9 M47.13 M 有利子負債合計 31.88 M28.63 M25.32 M22.28 M583 K 純負債 21.88 M18.63 M9.93 M1.19 M-29.56 M

ニュース

Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call Transcript

ベリカ・ファーマシューティカルズ、日本でのYCANTH発売で株価上昇

Verrica Pharmaceuticals stock rises after partner launches YCANTH in Japan

Verrica’s partner launches molluscum treatment in Japan

Verrica Pharmaceuticals (VRCA) Upgraded to Strong Buy: Here's Why

New Strong Buy Stocks for February 2nd

How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11%

ベリカ・ファーマシューティカルズ株式、TDコーエンの買い推奨維持で上昇

Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating

Verrica doses first patient in phase 3 trial for common wart treatment

ベリカ・ファーマシューティカルズ、チャールズ・フランツレブを取締役に任命し株式報酬を承認

Verrica Pharmaceuticals appoints Charles Frantzreb to board and approves equity grants